Journal article icon

Journal article

A phase III randomised controlled trial of single-dose triple therapy in COPD: the IMPACT protocol

Abstract:

Patients with symptomatic advanced chronic obstructive pulmonary disease (COPD) who experience recurrent exacerbations are particularly at risk of poor outcomes and present a significant burden on healthcare systems. The relative merits of treating with different inhaled combination therapies e.g. inhaled corticosteroids (ICS)/long-acting β2-agonist (LABA), LABA/long-acting muscarinic antagonists (LAMA), ICS/LABA/LAMA, in this patient group are poorly understood, as is reflected in current gu...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Accepted Manuscript

Actions


Access Document


Files:
Publisher copy:
10.1183/13993003.02165-2015

Authors


Pascoe, SJ More by this author
Lipson, DA More by this author
Locantore, N More by this author
Barnacle, H More by this author
Brealey, N More by this author
Expand authors...
Publisher:
European Respiratory Society Publisher's website
Journal:
European Respiratory Journal Journal website
Volume:
48
Issue:
2
Pages:
320-330
Publication date:
2016-07-31
Acceptance date:
2016-04-28
DOI:
EISSN:
1399-3003
ISSN:
0903-1936
Pubs id:
pubs:636583
URN:
uri:a2d48ccc-df98-4048-ba32-ea3933c7f3eb
UUID:
uuid:a2d48ccc-df98-4048-ba32-ea3933c7f3eb
Local pid:
pubs:636583

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP